The second possible molecular mechanism underlying CAV1-regulated hepatic steatosis might lie in the inhibition of PPARα, which is essential in the modulation of lipid metabolism as it activates the mitochondrial and peroxisomal fatty acid β-oxidation pathways [32]. The gene discussed is PPARA; the disease is Hepatic steatosis.